Characteristics of Human Leukocyte Antigen Class II Genes in Japanese Patients with Type 1 Diabetes and Autoimmune Thyroid Disease

被引:0
|
作者
Kajita, Risa [1 ]
Takahashi, Haruna [1 ]
Yoshino, Satoshi [1 ]
Matsumoto, Shunichi [1 ]
Horiguchi, Kazuhiko [1 ]
Okada, Shuichi [1 ]
Yamada, Masanobu [1 ]
Yamada, Eijiro [1 ]
机构
[1] Gunma Univ, Dept Med & Mol Sci, Grad Sch Med, 3-39-15 Showa machi Maebashi, Gunma 3718511, Japan
来源
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE | 2024年 / 263卷 / 02期
关键词
autoimmune thyroid disease; Graves' disease; human leukocyte antigen class II genes; Japanese patients; Type; 1; diabetes; HLA-DQ HAPLOTYPES; SUSCEPTIBILITY; MELLITUS; HETEROGENEITY; POLYMORPHISM; ASSOCIATION; MULTICENTER; GENETICS; ONSET;
D O I
10.1620/tjem.2024.J027
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Genetic factors, particularly human leukocyte antigen (HLA) class II genes, are known to significantly influence the onset of type 1 diabetes (T1D). Additionally, patients with T1D often develop autoimmune thyroid diseases (AITD). Despite this association, comprehensive research on individuals with both AITD and T1D in Japan, especially regarding the influence of specific HLA alleles, remains insufficient. In this retrospective study, we analyzed 44 inpatients diagnosed with T1D. These patients were predominantly female, with an average onset age of 35 years, poor blood sugar control, and approximately 43.2% had concurrent AITD. We observed significant associations of HLA-DRB1*04: 05, HLA-DRB1*09: 01 and HLA-DRB1*15:02 alleles with T1D regardless of AITD presence, which had been previously established for T1D in Japanese. In this context, comparing Japanese patients with AITD alone, we noted AITD comorbidity with T1D results in alterations in the frequencies of HLA-DRB1*09:01, HLA-DRB1*04:03, and HLA-DRB1*15:02. Furthermore, HLA-DRB1*04:05, HLA-DRB1*09:01, HLA-DRB1*13:02, and HLA-DRB1*15:01 alleles may be alleles whose susceptibility varies for both conditions. These findings underscore the importance of understanding the relationship between T1D, AITD, and HLA genetics, which may inform personalized treatment strategies and facilitate the development of targeted therapies. Future research endeavors should aim to elucidate underlying mechanisms and validate these findings in larger cohorts.
引用
收藏
页码:133 / 139
页数:7
相关论文
共 50 条
  • [41] Genetic susceptibility to type 1 diabetes in childhood - estimation of HLA class II associated disease risk and class II effect in various phases of islet autoimmunity
    Ilonen, J.
    Kiviniemi, M.
    Lempainen, J.
    Simell, O.
    Toppari, J.
    Veijola, R.
    Knip, M.
    PEDIATRIC DIABETES, 2016, 17 : 8 - 16
  • [42] Thyroid and Islet Autoantibodies Predict Autoimmune Thyroid Disease at Type 1 Diabetes Diagnosis
    Jonsdottir, Berglind
    Larsson, Christer
    Carlsson, Annelie
    Forsander, Gun
    Ivarsson, Sten Anders
    Lernmark, Ake
    Ludvigsson, Johnny
    Marcus, Claude
    Samuelsson, Ulf
    Ortqvist, Eva
    Larsson, Helena Elding
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2017, 102 (04): : 1277 - 1285
  • [43] Prevalence and incidence of thyroid dysfunction in type 1 diabetes, type 2 diabetes and latent autoimmune diabetes of adults: The Fremantle Diabetes Study Phase II
    Peters, Kirsten E.
    Chubb, Stephen A. Paul
    Bruce, David G.
    Davis, Wendy A.
    Davis, Timothy M. E.
    CLINICAL ENDOCRINOLOGY, 2020, 92 (04) : 373 - 382
  • [44] Association of single-nucleotide polymorphisms in tumour necrosis factor and human leukocyte antigens genes with type 1 diabetes
    Osman, Awad Elsid
    Brema, Imad
    AlQurashi, Alaa
    Al-Jurayyan, Abdullah
    Bradley, Benjamin
    Hamza, Muaawia Ahmed
    INTERNATIONAL JOURNAL OF IMMUNOGENETICS, 2021, 48 (04) : 326 - 335
  • [45] Genetic susceptibility and immunological synapse in type 1 diabetes and thyroid autoimmune disease
    Badenhoop, K
    Boehm, BO
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2004, 112 (08) : 407 - 415
  • [46] Arterial stiffness in Type 1 diabetes mellitus is aggravated by autoimmune thyroid disease
    Tryfonopoulos, D
    Anastasiou, E
    Protogerou, A
    Papaioannou, T
    Lily, K
    Dagre, A
    Souvatzoglou, E
    Papamichael, C
    Alevizaki, M
    Lekakis, I
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2005, 28 (07) : 616 - 622
  • [47] Type 1 diabetes, autoimmune thyroid disease, and chronic urticaria
    Hyman, Sharon J.
    Shreffler, Wayne G.
    Rapaport, Robert
    PEDIATRIC DIABETES, 2008, 9 (05) : 508 - 511
  • [48] Combining polygenic risk scores and human leukocyte antigen variants for personalized risk assessment of type 1 diabetes in the Taiwanese population
    Liao, Wen-Ling
    Huang, Yu-Nan
    Chang, Ya-Wen
    Liu, Ting-Yuan
    Lu, Hsing-Fang
    Tiao, Zih-Yu
    Su, Pen-Hua
    Wang, Chung-Hsing
    Tsai, Fuu-Jen
    DIABETES OBESITY & METABOLISM, 2023, 25 (10): : 2928 - 2936
  • [49] Impact of COVID-19 in immunosuppressive drug-naive autoimmune disorders: Autoimmune gastritis, celiac disease, type 1 diabetes, and autoimmune thyroid disease
    Santacroce, Giovanni
    Lenti, Marco Vincenzo
    Aronico, Nicola
    Miceli, Emanuela
    Lovati, Elisabetta
    Lucotti, Pietro Carlo
    Coppola, Luigi
    Gentile, Antonella
    Latorre, Mario Andrea
    Di Terlizzi, Francesco
    Soriano, Simone
    Frigerio, Chiara
    Pellegrino, Ivan
    Pasini, Alessandra
    Ubezio, Cristina
    Mambella, Jacopo
    Canta, Roberta
    Fusco, Alessandra
    Rigano, Giovanni
    Di Sabatino, Antonio
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2022, 33 : 105 - 107
  • [50] Home capillary sampling and screening for type 1 diabetes, celiac disease, and autoimmune thyroid disease in a Swedish general pediatric population: the TRIAD study
    Naredi Scherman, Maria
    Lind, Alexander
    Hamdan, Samia
    Lundgren, Markus
    Svensson, Johan
    Pociot, Flemming
    Agardh, Daniel
    FRONTIERS IN PEDIATRICS, 2024, 12